There are innumerable sick care startups and most of them are looking for pilot sites. Some get stuck in pilot purgatory.
Likewise, just about every major hospital or hospital system has an innovation center that is looking for deal flow. Here are 66 of them.
Similarly, there are dating services linking doctors who want to work with startups and vice versa.
Like any dating service, the problem is not the quantity of the members, but the quality of the members.
In the case of doctors:
In the case of sick care innovation centers, leaders and participants will need to address some issues to be effective and deliver impact:
1. The last mile. All the systems engineering in the world won't make a difference until we crack the code on how to change human behavior.
2. The rules. Most will have relatively limited impact until and unless the reimbursement rules substantially change. Rules drive ecosystems that create business models that deploy and scale innovation. Right now innovation centers are trying to use new tactics but can only deploy limited innovation strategies without a new playing field. They are living in the no man's land between the now and the new.
3. Systems thinking overcoming silos. Healthcare is notoriously siloed at almost every level, from department to department to one sick care system to the next.
4. Patient willingness and ability to engage. The assumption is that more patient "engagement" will be mean better outcomes. That needs to be validated and we need to do a better job of targeted patient segments who want to take responsibility for their care and assume the consequences for the results.
5. Shifting value factors. Medical care is becoming commoditized. Patients can't judge quality and cost since they are so opaque so they use service, speed, convenience and experience as proxies. There is relatively little correlation between satisfied patients and the quality of care they receive.
6. Data integration and interoperability. Resolving the protect but share dictum will be challenging.
7. Measuring and defining innovation. Big orbit change is necessary, not incrementalism. Innovation is a measure of the multiple of user defined value that results when compared to the existing competitive offering.
8. Lead innovators, don't manage innovation. We need leaderpreneurs and followers with an entrepreneurial mindset willing to fail at low cost.
9. Innovation management systems. There are many ways to foster, package, test, validate, prioritize and deploy components of an R/D portfolio. The process needs to efficient, effective and transparent to the users.
10. Execution. Inspiration and perspiration. In the end, no idea, invention, discovery, or process is worth much without a team who can execute or deploy it.
11. Long sales cycles prolonged processes of decision making.
12. Different business models to develop digital health and process improvement products.
13.Overcoming the main barriers to physician adoption: a) evidence based safety and effectiveness, b) concerns about liability, c) getting paid to do whatever you propose that d) will not interfere with workflow, take more time and further abbreviate face time with patients.
14. Entrepreneurs outperform intrapreneurs.
15. Incentives to participate.
We don't need another physician entrepreneur/hospital dating service. We need an innovation system that is user friendly, more efficient at derisking ideas and cheaper than what we have now. Unfortunately, you won't learn this in medical school or residency.
Arlen Meyers, MD, MBA is the President and CEO of Society of Physician Entrepreneurs.
Arlen Meyers, MD, MBA is a professor emeritus of otolaryngology, dentistry, and engineering at the University of Colorado School of Medicine and the Colorado School of Public Health and President and CEO of the Society of Physician Entrepreneurs at www.sopenet.org. He has created several medical device and digital health companies. His primary research centers around biomedical and health innovation and entrepreneurship and life science technology commercialization. He consults for and speaks to companies, governments, colleges and universities around the world who need his expertise and contacts in the areas of bio entrepreneurship, bioscience, healthcare, healthcare IT, medical tourism -- nationally and internationally, new product development, product design, and financing new ventures. He is a former Harvard-Macy fellow and In 2010, he completed a Fulbright at Kings Business, the commercialization office of technology transfer at Kings College in London. He recently published "Building the Case for Biotechnology." "Optical Detection of Cancer", and " The Life Science Innovation Roadmap". He is also an associate editor of the Journal of Commercial Biotechnology and Technology Transfer and Entrepreneurship and Editor-in-Chief of Medscape. In addition, He is a faculty member at the University of Colorado Denver Graduate School where he teaches Biomedical Entrepreneurship and is an iCorps participant, trainer and industry mentor. He is the Chief Medical Officer at www.bridgehealth.com and www.cliexa.com and Chairman of the Board at GlobalMindED at www.globalminded.org, a non-profit at risk student success network. He is honored to be named by Modern Healthcare as one of the 50 Most Influential Physician Executives of 2011 and nominated in 2012 and Best Doctors 2013.
Leave your comments
Post comment as a guest